Dr Jibani's interest in kidney disease emerged from his intensive care training.
Within 120 days of starting treatment there were 4691 hospitalizations for acute kidney injury in patients without pre-existing kidney disease and 1896 hospitalizations in patients with pre-existing disease.
FORBES: High Potency Statins Linked To Increased Risk For Acute Kidney Injury
Another, called SHARP, compares Vytorin, Zocor and placebo in patients with kidney disease.
That leaves doctors who want more proof of the drug's efficacy to wait for a study in patients with kidney disease.
Peto's analysis looked at data taken from two incomplete studies of Vytorin: SHARP, which compares Vytorin with a placebo in patients with kidney disease, and IMPROVE-IT, which compares Vytorin with Zocor.
"Putting the cost of care aside, for individuals the late identification of kidney disease means delays in diagnosis with a failure to manage risk factors including heart attacks, strokes and progressive kidney disease, " he said.
HgA1C values may be elevated or decreased in those with chronic kidney disease.
He developed kidney disease in the 1990s and had a transplant in 2001.
Satel herself went through a harrowing 18-month wait for a donor organ after she was diagnosed with kidney disease in 2004.
Researchers hope their findings will lead to treatments for diseased cilia, which can cause blindness, deafness and kidney disease in people.
Dr Donal O'Donoghue, national clinical director for Kidney Care, described the report as a "wake-up call" for everyone involved in the fight against kidney disease.
Although it had been the subject of earlier questions, serious criticism emerged with the publication in 2009 of the TREAT trial, which found no clinical benefit for the drug in patients with chronic kidney disease.
FORBES: Amgen Pleads Guilty To Misbranding Anemia Drug Aranesp
Aranesp is approved to treat anemia in chemotherapy patients and in anemia patients with chronic kidney disease.
FORBES: Amgen Pleads Guilty To Misbranding Anemia Drug Aranesp
The drug was being tested in patients with stage 4 chronic kidney disease and type 2 diabetes.
FORBES: For Abbott, Setbacks Happen In Threes; Now, A Kidney Drug Trial Ends Over Deaths
Kidney disease was present in 9.4% of the people without diabetes, and 42.3% of those with diabetes.
Sanofi has its hands in just about everything, though it is particularly strong in its diabetes and cancer drugs and in treatments for heart disease and kidney disease.
Afinitor delayed disease progression in patients with kidney cancer by a modest three months in a 416-patient trial led by Robert Motzer, an oncologist at Memorial Sloan-Kettering Cancer Center.
Shares of Questcor Pharmaceuticals (No. 7), which makes drugs for multiple sclerosis and kidney disease, were crushed in September after Aetna stopped reimbursing for most uses of its Acthargel and the feds launched an investigation into marketing practices.
FORBES: Small Caps With Fat Dividends Include True Religion, Questcor
He died in October following a battle with dementia, kidney disease, heart disease and stomach cancer.
In the late 1990s, De Preist contracted kidney disease and had to go on dialysis.
The RED-HF investigators noted that this observation was consistent with an elevated risk for stroke associated with darbepoetin alfa found in the TREAT trial of patients with diabetes, chronic kidney disease, and anemia.
Richard has fought off breast cancer twice, but in January was told the disease had spread to her right kidney and bones.
In 2002, Pakistani President Pervez Musharraf said bin Laden had kidney disease, for which he required a dialysis machine, and was therefore likely dead.
Epogen's main use is to treat anemia in patients with kidney failure, also known as end-stage renal disease.
But it is also effective in lowering cholesterol and reducing your risk for heart disease, stroke, kidney stones and diabetes, its website states.
There have been no clinical trials to assess the effect of higher doses, although two other studies done on less-sick patients might suggest the higher doses are problematic--one in 1998 for patients with cardiac disease and one last year for chronic kidney disease patients.
Just three months before its planned split into two companies, Abbott Laboratories is suffering a significant setback after a Phase III trial for a chronic kidney disease treatment was ended due to an excessive number of deaths and serious adverse events in patients.
FORBES: For Abbott, Setbacks Happen In Threes; Now, A Kidney Drug Trial Ends Over Deaths
In the United States, about 65, 000 new cases of kidney cancer and 13, 700 deaths from the disease are expected this year.
The large and growing cohort of diabetics in this country will drive major increases to overall healthcare costs due to treating the downstream consequences of this disease including kidney disease, amputations, blindness and heat attacks.
FORBES: The 'Obesity Paradox' -- Is It Healthy To Be Overweight?
应用推荐